FLUDARA

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

FLUDARABINE PHOSPHATE 50 MG/VIAL

متاح من:

SANOFI - AVENTIS ISRAEL LTD

ATC رمز:

L01BB05

الشكل الصيدلاني:

POWDER FOR SOLUTION FOR INJ/INF

طريقة التعاطي:

I.V

المصنعة من قبل:

GENZYME EUROPE B.V., NETHERLANDS

المجموعة العلاجية:

FLUDARABINE

الخصائص العلاجية:

Palliative treatment of patients with CLL refractory to other therapy. Treatment of less malignant Non-Hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. Fludara is indicated for the initial treatment of patients with B- cell chronic lymphocytic leukaemia (CLL) or after first line therapy, in patients with sufficient bone marrow reserves.

تاريخ الترخيص:

2009-02-01